Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies (Q34758477)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies |
scientific article |
Statements
1 reference
Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies (English)
1 reference
Razelle Kurzrock
1 reference
Apostolia M Tsimberidou
1 reference
Aung Naing
1 reference
David S Hong
1 reference
Maria E Cabanillas
1 reference
Jennifer Wheler
1 reference
Lei Ye
1 reference
Naifa L Busaidy
1 reference
Steven G Waguespack
1 reference
Mike Hernandez
1 reference
Adel K El Naggar
1 reference
Savita Bidyasar
1 reference
John Wright
1 reference
Steven I Sherman
1 reference
2 February 2011
1 reference
1 reference
96
1 reference
4
1 reference
997-1005
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference